XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Signifcant Contracts and Concentrations - Halson Master License (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
May 15, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Subsequent Event [Line Items]            
Purchaseable stock   19,800,053   19,800,053   19,624,860
Deferred revenue, current   $ 889   $ 889   $ 88
Deferred revenue, long-term liability   3,875   3,875    
Licensing revenue   $ 2,637 $ 4,501 $ 15,468 $ 21,715  
Sales [Member] | Customer Concentration Risk [Member] | Halston License            
Subsequent Event [Line Items]            
Concentration risk, percentage   25.00%   6.00%    
Net licensing revenue            
Subsequent Event [Line Items]            
Licensing revenue   $ 2,381 $ 2,166 $ 7,031 $ 13,302  
Halston License            
Subsequent Event [Line Items]            
Additional royalty payable term 20 years          
Total purchase price $ 5,000          
Warrant term 10 years          
Purchaseable stock   1,000,000   1,000,000    
Deferred revenue   $ 4,670   $ 4,670    
Deferred revenue, current   890   890    
Deferred revenue, long-term liability   3,780   $ 3,780    
Recognition period of deferred revenue       5 years 6 months    
Contra-revenue related to warrants granted to licensee       $ 20    
Halston License | Minimum            
Subsequent Event [Line Items]            
Royalty payable term 5 years          
Halston License | Maximum            
Subsequent Event [Line Items]            
Royalty payable term 25 years          
Halston License | Warrants            
Subsequent Event [Line Items]            
Purchaseable stock 1,000,000          
Warrants outstanding, exercise price (in dollars per share) $ 1.50          
Number of shares vested       0    
Halston License | Net licensing revenue            
Subsequent Event [Line Items]            
Licensing revenue   $ 650   $ 980